MIANSERIN

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID1235
Ligand NameMIANSERIN
PubMed Compound Id4184
StructureProduct Image
Molecular FormulaC18H20N2
Molecular Weight264.4
SMILESCN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42
Synonymsmianserin
Mianserine
24219-97-4
Mianserina
Mianserinum
Tolvon
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
CHEBI:51137
250PJI13LM
DTXSID6023317
J16.389I
DTXCID003317
Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-
Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-
1,2,3,4,10,14b-hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine
1,2,3,4,10,14B-HEXAHYDRO-2-METHYLDIBENZO(C,F)-PYRAZINO(1,2-A)AZEPINE
5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene
5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene
5-methyl-2,5-diazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(15),8(13),9,11,16,18-hexaene
5-methyl-2,5-diazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(19),8,10,12,15,17-hexaene
RefChem:158482
N06AX03
246-088-6
Mianseryna [Polish]
Mianseryna
Mianserine [INN-French]
Mianserinum [INN-Latin]
Mianserina [INN-Spanish]
2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
Mianserin (INN)
CHEMBL6437
NCGC00015656-06
MIANSERIN [INN]
Mianserin [INN:BAN]
5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene
(S)-(+)-Mianserin
CAS-24219-97-4
Tolvon (TN)
(+/-)-Mianserin
HSDB 7182
EINECS 246-088-6
BRN 0755346
UNII-250PJI13LM
mianserin a
Mianserin?
S(+)-Mianserin
(+-)-Athymil
Spectrum_001810
PS32 - Mianserin
MIANSERIN [MI]
MIANSERIN [HSDB]
Prestwick0_000099
Prestwick1_000099
Prestwick2_000099
Prestwick3_000099
Spectrum2_001203
Spectrum3_001836
Spectrum4_001260
Spectrum5_001772
MIANSERIN [VANDF]
Biomol-NT_000135
MIANSERIN [WHO-DD]
Lopac0_000744
Oprea1_703627
SCHEMBL18020
BSPBio_000058
BSPBio_003511
GTPL135
KBioGR_001820
KBioSS_002303
cid_68551
DivK1c_000844
SPBio_000986
SPBio_001997
BPBio1_000064
BPBio1_000331
orb1705061
SCHEMBL29356897
BDBM31005
KBio1_000844
KBio2_002301
KBio2_004869
KBio2_007437
KBio3_003016
NINDS_000844
HMS2089A04
BCA15288
HY-B0188
Tox21_110191
AC-631
BDBM50222218
PDSP1_001532
PDSP2_001516
AKOS005216268
Tox21_110191_1
CCG-204829
CS-2078
DB06148
SDCCGSBI-0050722.P004
IDI1_000844
NCGC00015656-04
NCGC00015656-05
NCGC00015656-08
NCGC00015656-09
NCGC00015656-10
NCGC00015656-12
NCGC00015656-23
NCGC00024926-03
NCGC00024926-04
DA-65446
TS-08152
SBI-0050722.P003
NS00010650
D08216
EN300-18559884
L000736
Q416701
BRD-A19661776-001-01-5
BRD-A19661776-003-05-2
BRD-A19661776-003-16-9
BRD-A19661776-003-25-0
BRD-A19661776-003-26-8
BRD-A19661776-003-27-6
BRD-A19661776-003-28-4
2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine #
Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine; (+/-)-Mianserin; Mianserin; Mianserine
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm